SELECT trial (17,500+ participants): Confirmed semaglutides cardiovascular benefits and validated its long-term safety profile in people with obesity and established heart disease
In PIONEER-9, oral semaglutide induced nausea in up to 10% of patients, whereas none of the liraglutide patients had nausea (liraglutide was low-dose however) ( Finally, in a network meta-analysis, several short- and long-acting GLP-1RA were compared regarding efficacy and side effect profile
Programs like Noom can help and support these lifestyle changes
GLP-1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apnea
By the end of the first month, the average patient on starting doses sees 24 pounds of loss, though individual results vary widely based on diet adherence, exercise, sleep, and genetics
Meaning if youre an athlete and it shows up on a drug test, you are disqualified from your event